Welcome to Advanced Search

Models

About 616 results
Cells

LS 180

Strain Name:LS 180
Strain State : Validation of tumorigenic capacity completed |  Cat. NO.:NM-J08

Human colon cancer tumor cell line

Cells

MKN45

Strain Name:MKN45
Strain State : Validation of tumorigenic capacity completed |  Cat. NO.:NM-W07

Human gastric cancer cell line

Cells

HCC1569

Strain Name:HCC1569
Strain State : Validation of tumorigenic capacity completed |  Cat. NO.:NM-R19

human breast cancer cell line

Cells

NCI-H716

Strain Name:NCI-H716
Strain State : Validation of tumorigenic capacity completed |  Cat. NO.:NM-J16

human colon cancer cell

Cells

Mki67-tdTomato-2A-Luc

Strain Name:Mki67-tdTomato-2A-Luc
Strain State : Construction |  Cat. NO.:NM-YD12

Derived from Mki67-tdTomato-2A-Luc mice spontaneous lung cancer model

Cells

R26-CAG-loxp-tdTomato-loxp2272-Tag-IRES-EGFP-2A-Luc-loxp-loxp2272/Alb-Cre-Tg

Strain Name:R26-CAG-loxp-tdTomato-loxp2272-Tag-IRES-EGFP-2A-Luc-loxp-loxp2272/Alb-Cre-Tg
Strain State : Construction |  Cat. NO.:NM-YD14

Derived from R26-CAG-loxp-tdTomato-loxp2272-Tag-IRES-EGFP-2A-Luc-loxp-loxp2272/Alb-Cre-Tg mice spontaneous liver cancer model

Cells

MC38-OVA-Luc (2)

Strain Name:MC38-OVA-Luc
Strain State : Validation of tumorigenic capacity completed |  Cat. NO.:NM-S13-TG69

The MC38-OVA-Luc cell line is the MC38 colon cancer tumor cell line expressing OVA gene and protein.

Cells

Rb1-Flox/Trp53-Flox/R26-CAG-LSL-Luc-2A-EGFP

Strain Name:Rb1-Flox/Trp53-Flox/R26-CAG-LSL-Luc-2A-EGFP
Strain State : Construction |  Cat. NO.:NM-YD16

Derived from Rb1-Flox/Trp53-Flox/R26-CAG-LSL-Luc-2A-EGFP mice(NM-KI-234513) spontaneous lung cancer model

Cells

R26-CAG-LSL-Kras*G12C-IRES-Luc(BABL/c)

Strain Name:R26-CAG-LSL-Kras*G12C-IRES-Luc(BABL/c)
Strain State : 成瘤验证完成 |  Cat. NO.:NM-YD15

Derived from R26-CAG-LSL-Kras*G12C-IRES-Luc(BABL/c) mice(NM-KI-200324) spontaneous lung cancer model

Cells

ACHN

Strain Name:ACHN
Strain State : Validation of tumorigenic capacity |  Cat. NO.:NM-SA03

Human kidney cancer cell line

Email Back to top